PARIS (Reuters) - Sanofi-Aventis (SASY.PA: Quote, Profile, Research), the world’s third-largest drugmaker, said on Tuesday it had won clearance from Japanese authorities to market its blood-thinner treatment product Plavix in Japan.
PARIS (Reuters) - Sanofi-Aventis (SASY.PA: Quote, Profile, Research), the world’s third-largest drugmaker, said on Tuesday it had won clearance from Japanese authorities to market its blood-thinner treatment product Plavix in Japan.
